NYSE:HQL

Tekla Life Sciences Investors Stock News

etoro logo Buy HQL
*Your capital is at risk
$18.63
+0.290 (+1.58%)
At Close: Jun 23, 2026
Just a few months after GlaxoSmithKline penned a $50 million deal with biotech Immatics for its T-cell work, the executive running the Big Pharma’s cancer cell therapy unit is upping sticks to join
After swinging the ax on staffers last year and gaining a new CEO a few months back, Five Prime Therapeutics’ clinical development lead is hoping for a more stable time at new employer Spectrum Phar
Gilead and Galapagos have released 52-week clinical trial data showing the durability of filgotinib in rheumatoid arthritis patients. The update comes as the partners close in on a FDA approval that w
Athira Pharma changed its name last year to reflect its focus on regenerative medicine. Now, it’s snagged $85 million to advance those medicines, which includes bankrolling a phase 2/3 trial in Alzh
Since it launched in 2018, Accent Therapeutics has busied itself discovering new targets for cancer drugs in the space of RNA-modifying proteins. But the time for lying low is over—just weeks after
On May 29, 2020, Tekla Healthcare Opportunities Fund paid a monthly distribution of $0.1125 per share. It is currently estimated that this distribution is derived from return of capital or other capit

Tekla World Healthcare Fund Paid Distribution

02:17pm, Friday, 29'th May 2020
On May 29, 2020, Tekla World Healthcare Fund paid a monthly distribution of $0.1167 per share. It is currently estimated that this distribution is derived from return of capital or other capital sourc

Tekla World Healthcare Fund Paid Distribution

12:00am, Friday, 29'th May 2020
On May 29, 2020, Tekla World Healthcare Fund paid a monthly distribution of $0.1167 per share. It is currently estimated that this distribution is der
The industrial automation market size in the life sciences industry will grow by USD 1.92 billion during 2020-2024
HotSpot Therapeutics set out two years ago to find new ways to address elusive disease targets. It now has molecules on the path to becoming potential
One of the risks to a newborn’s life comes from the mother’s immune system. It attacks the platelets of the fetus, depleting these blood-clotting cells
Rallybio, a biopharmaceutical company committed to identifying and accelerating the development of life-transforming therapies for patients with sever
On May 18, 2020, Tekla Life Sciences Investors declared a stock distribution of $0.34 per share. The record date for the stock distribution is May 29, 2020 and the payable date is June 30, 2020. The F
On May 8, 2020, Tekla World Healthcare Fund declared its monthly cash distribution of $0.1167 per share. The record date for the monthly cash distribution is May 20, 2020 and the payable date is May 2
On May 8, 2020, Tekla Healthcare Opportunities Fund declared its monthly cash distribution of $0.1125 per share. The record date for the monthly cash
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE